# Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode

> **NCT02019030** · — · TERMINATED · sponsor: **Olympus Corporation of the Americas** · enrollment: 5 (actual)

## Conditions studied

- Benign Prostatic Hyperplasia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02019030
- **Lead sponsor:** Olympus Corporation of the Americas
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2013-12
- **Primary completion:** 2017-01-03
- **Final completion:** 2017-01-03
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Not meeting enrollment goals
- **Last updated:** 2018-04-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02019030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02019030, "Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02019030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*